More news on this day
The United States has issued a travel alert for Costa Rica after health authorities reported a sharp rise in cases of chikungunya, a painful mosquito-borne illness, in one of the country’s most popular vacation regions.
Get the latest news straight to your inbox!

Alert Centers on Guanacaste, a Major Beach Tourism Hub
According to publicly available information from the U.S. Centers for Disease Control and Prevention, Costa Rica is now under a Level 2 Travel Health Notice for chikungunya, meaning travelers are advised to practice enhanced precautions. The notice, updated in mid-July 2026, cites an ongoing outbreak in Guanacaste Province, a Pacific coast region known for its beach resorts, surf towns, and all-inclusive hotels that draw hundreds of thousands of U.S. visitors each year.
Reports indicate that local health authorities in Costa Rica have documented growing numbers of chikungunya infections in coastal communities, including areas close to major tourist beaches. The pattern reflects wider regional data from the Pan American Health Organization, which has tracked sustained increases in chikungunya cases across parts of the Americas since late 2025.
Publicly accessible travel health guidance notes that tourism dynamics in Guanacaste, with large flows of international visitors, dense coastal development, and a warm, humid climate, can facilitate the spread of viruses carried by Aedes mosquitoes. These conditions place both local residents and travelers at heightened risk when outbreaks occur.
U.S. travel medicine specialists who contribute to national surveillance systems have also highlighted Costa Rica in recent months as a destination where mosquito-borne illnesses, including dengue and chikungunya, are being reported with greater frequency among returning travelers.
Painful Virus Can Disrupt Trips for Weeks
Chikungunya is caused by a virus transmitted primarily by Aedes aegypti and Aedes albopictus mosquitoes, the same species that spread dengue and Zika. Health guidance describes the illness as typically sudden in onset, marked by high fever and intense joint pain that can be debilitating. Other common symptoms include headache, muscle pain, fatigue, and rash.
Clinical summaries published by international and U.S. health agencies state that most patients begin to feel ill within three to seven days after being bitten by an infected mosquito. While fatalities are uncommon, joint pain can last for weeks or even months, and in some individuals it may evolve into longer-term inflammatory problems that resemble arthritis.
Travel health advisories warn that certain groups, including older adults, pregnant people, newborns, and individuals with underlying conditions such as diabetes or heart disease, face a higher risk of complications. In severe cases, chikungunya can contribute to neurologic, cardiovascular, or other systemic problems that may require hospitalization.
There is currently no widely available antiviral treatment that targets chikungunya directly. Management is focused on rest, fluids, and medications to reduce fever and pain, which underscores the importance of preventing mosquito bites in the first place, especially in areas where outbreaks are ongoing.
No Routine Vaccine for Travelers, Making Prevention Critical
Publicly available information from regulatory and health agencies indicates that although a chikungunya vaccine has been licensed in certain settings, it is not in routine use for most international travelers and remains primarily targeted to specific high-risk populations. As a result, the principal protection for U.S. tourists heading to Costa Rica continues to be meticulous mosquito bite prevention.
Standard recommendations for travelers to Guanacaste and other affected parts of Costa Rica emphasize using insect repellents containing ingredients such as DEET, picaridin, or oil of lemon eucalyptus, wearing long sleeves and long pants when feasible, and staying in accommodations with air conditioning or well-screened windows and doors. Mosquitoes that spread chikungunya are daytime biters, so protection is advised both during outdoor activities and inside lodgings where mosquitoes may be present.
Travel health guidance also encourages visitors to take simple vector-control measures at hotels, rental homes, and guesthouses. These include eliminating standing water in containers where mosquitoes can breed, such as buckets, plant saucers, and outdoor gear, particularly in garden or patio areas common in tropical vacation properties.
Given the current outbreak status, health agencies recommend that travelers who are pregnant or planning pregnancy consult a healthcare provider before booking trips to areas with active chikungunya transmission. Specialists can help weigh individual risk factors and discuss whether travel should be deferred or additional precautions are warranted.
Rising Mosquito-Borne Risks Across the Americas
The alert for Costa Rica is unfolding against a broader backdrop of increasing mosquito-borne disease activity in the Americas. An epidemiological alert from the Pan American Health Organization earlier in 2026 described a sustained rise in chikungunya cases in multiple countries in the region, along with ongoing dengue transmission and localized circulation of other arboviruses.
U.S. surveillance reports have noted higher numbers of travel-associated dengue and chikungunya cases in recent years, with many linked to popular Latin American and Caribbean vacation destinations. Health authorities stress that as long as Aedes mosquitoes are present in parts of the United States, infected travelers returning from outbreak areas can, in limited circumstances, contribute to local transmission.
Climate variability, rapid urbanization, and expanding tourism infrastructure have all been cited in public analyses as factors that can intensify mosquito breeding and bring more people into contact with disease vectors. Coastal resort regions, where large seasonal populations converge in relatively compact areas, are considered especially vulnerable when outbreaks occur.
The Costa Rica notice also comes at a time when other destinations are facing heightened mosquito-borne risks, from dengue clusters in tropical islands to localized alerts in U.S. states. Travel health experts say this convergence underscores the need for travelers to treat mosquito protection as a routine part of trip planning rather than an optional extra.
What U.S. Travelers Should Do Before and After Visiting Costa Rica
U.S. residents planning trips to Costa Rica are being urged, through publicly available advisories, to review the latest travel health notices close to their departure date and to consult a travel clinic or primary care provider four to six weeks before travel. This allows time to discuss destination-specific risks, update routine vaccines, and prepare a personal travel health kit.
Travel guidance recommends that individuals with chronic medical conditions, older adults, and pregnant travelers pay particular attention to protective measures and consider whether the current situation in Guanacaste aligns with their risk tolerance. Some travelers may choose to adjust itineraries to spend more time in areas with lower reported activity, while others may decide to postpone travel until case numbers decline.
After returning from Costa Rica or other affected areas, travelers are advised to seek medical evaluation if they develop fever, joint pain, severe headache, or rash within two weeks of their trip. Health providers use travel history as a key clue when evaluating possible arboviral infections and can arrange appropriate laboratory testing and supportive care.
Publicly available health communications also note that travelers who become ill shortly after returning should continue to use mosquito precautions at home, such as repellents and window screens, to reduce the chance that local mosquitoes could bite them and potentially spread the virus further. In the context of a rising burden of mosquito-borne disease across the Americas, individual preventive steps during and after travel are seen as an important line of defense.